E.g., 02/18/2020
E.g., 02/18/2020

bioMérieux submits enhanced BIOFIRE® BCID2 Panel for FDA clearance

14 January, 2020

bioMérieux, a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clearance of the BIOFIRE® Blood Culture Identification 2 (BCID2) Panel. The BIOFIRE® BCID2 Panel includes several additional pathogens, an expanded list of antimicrobial resistance genes, and many revised targets compared to the existing BIOFIRE® BCID Panel.

bioMérieux – Second-Quarter 2016 Business Review

18 July, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today released its quarterly business review for the six months ended June 30, 2016.

bioMérieux enlarges its pathogen identification capability on VITEK® MS

06 July, 2016

With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases.

bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT™ Test for Managing Sepsis Patients with Elevated Risk of Mortality

01 July, 2016

Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients.

bioMérieux acquires Hyglos

01 June, 2016

bioMérieux acquires Hyglos and expands its offering to the detection of endotoxins in pharmaceutical products.

bioMérieux and the Lyon Civil Hospitals strengthen their collaboration

31 May, 2016

bioMérieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1 Two joint research laboratories focused on a common goal: advancing medical research for the benefit of patients.

bioMérieux – First-Quarter 2016 Business Review

20 April, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2016.

Pioneering diagnostics